Mean platelet volume for differentiating non-alcoholic fatty liver disease from non-alcoholic steatohepatitis: Is it ready for prime time?

被引：1
|
作者：
Madan, Kaushal [1 ]
Garg, Pallavi [1 ]
机构：
[1] Max Hosp, Max Ctr Gastroenterol Hepatol & Endoscopy, New Delhi 110017, India
来源：
INDIAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 42卷 / 02期
关键词：
ASSOCIATION; MARKER;
D O I：
10.1007/s12664-023-01381-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：156 / 157
页数：2
相关论文
共 50 条
  • [1] Is mean platelet volume a simple marker of non-alcoholic fatty liver disease?
    Karaogullarindan, Umit
    Uskudar, Oguz
    Odabas, Emre
    Saday, Melike
    Akkus, Gamze
    Delik, Anil
    Gumurdulu, Yuksel
    Kuran, Sedef
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2023, 42 (02) : 219 - 225
  • [2] Navigating the Link Between Non-alcoholic Fatty Liver Disease/ Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome
    Gato, Sheila
    Garcia-Fernandez, Vanessa
    Gil-Gomez, Antonio
    Rojas, Angela
    Montero-Vallejo, Rocko
    Munoz-Hernandez, Rocko
    Romero-Gomez, Manuel
    EUROPEAN CARDIOLOGY REVIEW, 2024, 19
  • [3] Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A focused literature review
    Eguchi, Yuichiro
    Wong, Gabriel
    Lee, Emma
    Akhtar, Omar
    Lopes, Ricardo
    Sumida, Yoshio
    JGH OPEN, 2020, 4 (05): : 808 - 817
  • [4] Machine learning to predict progression of non-alcoholic fatty liver to non-alcoholic steatohepatitis or fibrosis
    Ghandian, Sina
    Thapa, Rahul
    Garikipati, Anurag
    Barnes, Gina
    Green-Saxena, Abigail
    Calvert, Jacob
    Mao, Qingqing
    Das, Ritankar
    JGH OPEN, 2022, 6 (03): : 196 - 204
  • [5] Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
    Tacke, Frank
    Weiskirchen, Ralf
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [6] Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring
    Long, Michelle T.
    Gurary, Ellen B.
    Massaro, Joseph M.
    Ma, Jiantao
    Hoffmann, Udo
    Chung, Raymond T.
    Benjamin, Emelia J.
    Loomba, Rohit
    LIVER INTERNATIONAL, 2019, 39 (04) : 740 - 747
  • [7] The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease
    Goh, George B. B.
    Issa, Danny
    Lopez, Rocio
    Dasarathy, Srinivasan
    Dasarathy, Jaividhya
    Sargent, Ruth
    Hawkins, Carol
    Pai, Rish K.
    Yerian, Lisa
    Khiyami, Amer
    Pagadala, Mangesh R.
    Sourianarayanane, Achuthan
    Alkhouri, Naim
    McCullough, Arthur J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) : 995 - 1000
  • [8] A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD
    Younossi, Zobair M.
    Stepanova, Maria
    Henry, Linda
    Racila, Andrei
    Lam, Brian
    Pham, Huong T.
    Hunt, Sharon
    LIVER INTERNATIONAL, 2017, 37 (08) : 1209 - 1218
  • [9] S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis
    Liu, Xiaolin
    Wang, Yongfeng
    Ming, Yanan
    Song, Yanyan
    Zhang, Jingyi
    Chen, Xiaoyu
    Zeng, Minde
    Mao, Yimin
    PLOS ONE, 2015, 10 (05):
  • [10] Effects of saroglitazar in the treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis
    Bandyopadhyay, Sanjay
    Samajdar, Shambo Samrat
    Das, Saibal
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (07)
12345